| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261455.1 |
AKT inhibitor VIII |
Colon adenocarcinoma |
0.043879825 |
Resistant |
| ENSG00000261455.1 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.012218845 |
Resistant |
| ENSG00000261455.1 |
AKT inhibitor VIII |
Stomach adenocarcinoma |
0.037620637 |
Sensitive |
| ENSG00000261455.1 |
AKT inhibitor VIII |
Thyroid carcinoma |
0.044977911 |
Sensitive |
